Wuhan Greenovo Biotechnology Co., LTD (Hereinafter referred to as “Greenovo”) was established at Hi-Tech Development Zone on February 14, 2012 in Wuhan, China. It is a high-tech enterprise that focused on the research, manufacture and marketing of biomedical materials.
Unlike other hemostatic devices, Greenovo products are impregnated with kaolin, a naturally occurring, inorganic mineral (clay derivative).Kaolin has no known allergic or exothermic reactions. Greenovo products are safe and effective, having passed all biocompatibility testing, and do not contain any animal or human-derived proteins or shellfish products.Greenovo is the essential choice for hemorrhage control in a broad range of bleeding situations.